Efficacy and Safety of Remibrutinib in Chronic Inducible Urticaria: Results of Phase 3 RemIND Study

Chronic inducible urticaria is more common than its limited recognition suggests, spans many distinct subtypes, and carries a substantial psychological toll. Accurate diagnosis depends on history and, ideally, standardized provocation testing.

Behind each diagnosis is a patient whose work, recreation, and sense of normalcy have been quietly constrained. Personal accounts from both clinicians show why quality-of-life questions belong in every urticaria visit.